Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090249
Company: IPCA LABS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE EQ 300MG BASE TABLET;ORAL Prescription AA No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/03/2009 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/28/2015 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

CHLOROQUINE PHOSPHATE

TABLET;ORAL; EQ 300MG BASE
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE EQ 300MG BASE TABLET;ORAL Prescription No AA 083082 HIKMA PHARMS
CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE EQ 300MG BASE TABLET;ORAL Prescription No AA 090249 IPCA LABS LTD
CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE EQ 300MG BASE TABLET;ORAL Prescription No AA 090612 NATCO PHARMA LTD

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English